As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
Announcement: COVID-19 impact on peer review
Celebrating Fifteen Years
Retrovirology is celebrating its fifteenth year as a leader in human and animal retrovirus research.
Join us as we look back at some of the journal's highlights and milestones as we look forward to the next fifteen years.
Calls For Papers
- HTLV-1: a re-emerging human pathogen
- Endogenous Retroviruses in Evolution and Disease
- Previous Thematic Series
The Editors of Retrovirology are proud to announce that 'HTLV-1: a re-emerging human pathogen' is now open for submissions on HTLV-1 replication, pathogenesis, treatment and prevention and identify essential areas of unmet need in HTLV-1 basic and translational research.
Currently open for submissions - Submit an article to the series.
The Editors-in-Chief of Retrovirology and Mobile DNA extend an invitation to submit original research articles related to endogenous retroviruses. We hope this will inspire new submissions to the collection that can provide further insights in to the role of endogenous retroviruses in evolution and disease.
Currently open for submissions - Submit an article to Retrovirology for the series.
Previous Thematic Series
Broadly neutralizing antibodies (bnAbs) against HIV
Edited by Rogier Sanders and Marit van Gils
Measuring HIV-1 persistence in vivo
Edited by Ben Berkhout and Alexander Pasternak
Disruptive technologies in retrovirus research
Edited by Johnson Mak
We are pleased to announce that Retrovirology is accepting articles with graphical abstracts, capturing the articles content in a single image for our readers. For more information, please see our Submission Guidelines.
Blogs From Our Authors
Johnson Mak, Institute for Glycomics, Griffith University, Australia
Susan Ross, University of Illinois at Chicago, USA
Andrew Lever, University of Cambridge, UK
Kuan-Teh Jeang, National Institutes of Health, USA
Aims and scope
Retrovirology is an open access, online journal that publishes stringently peer-reviewed, high-impact articles on host-pathogen interactions, fundamental mechanisms of replication, immune defenses, animal models, and clinical science relating to retroviruses. Retroviruses are pleiotropically found in animals. Well-described examples include avian, murine and primate retroviruses.
Two human retroviruses are especially important pathogens. These are the human immunodeficiency virus, HIV, and the human T-cell leukemia virus, HTLV. HIV causes AIDS while HTLV-1 is the etiological agent for adult T-cell leukemia and HTLV-1-associated myelopathy/tropical spastic paraparesis. Retrovirology aims to cover comprehensively all aspects of human and animal retrovirus research.
Save the date: Frontiers of Retrovirology Conference 2020
Johnson Mak, Editor-in-Chief
Professor Mak is a native of Hong Kong who undertook his undergraduate and post-graduate training at McGill University in Montreal, Canada. During his PhD Johnson worked with Professor Lawrence Kleiman at the McGill AIDS Centre studying packaging of primer tRNA into HIV. He subsequently moved to Melbourne, Australia to continue work on HIV assembly at the Burnet Institute under the guidance of Professor Suzanne Crowe. He is currently a Professor at the Institute for Glycomics, Griffith University, Gold Coast. He has a broad research portfolio in HIV having studied primer tRNAs in retroviruses, genomic RNA packaging and dimerization, cholesterol and lipids in HIV, viral-host interactions, imaging of HIV and analysis of recombination and mutation in HIV using next generation sequencing. His team pioneered the production of full-length recombinant HIV Gag for biochemical and biophysical analyses of HIV assembly. Recently Johnson and his team have described a pre-entry priming process for HIV.
Susan Ross, Editor-in-Chief
Susan R. Ross, PhD is Sweeney Basic Sciences Professor of and Head of the Department of Microbiology and Immunology at the UIC College of Medicine. Dr. Ross's research interests are in the genetics of host-virus interactions, particularly retroviruses and new world arenaviruses. Dr. Ross was on the faculty in Biochemistry at UIC from 1983-94. In 1994, she moved to the Microbiology Department at the University of Pennsylvania, where she also served as Associate Dean for Biomedical Graduate Studies from 2002-12. In 2015, she moved to UIC to assume the Head position.
Dr. Ross has served on numerous review panels and editorial boards, including the Recombinant DNA Advisory Committee of the NIH, Senior Editor for the Journal of Virology, Section Editor of PLOS Pathogens and on the Editorial Committee of the Annual Review of Virology. Dr. Ross has received several awards for teaching and research, including the ASM Wellcome Visiting Professorship, the ASM International Professorship and the Center for Retrovirus Research Distinguished Research Career Award (Ohio State University). Dr. Ross was elected a Fellow of the American Academy of Microbiology in 2002 and an AAAS Fellow in 2009.
Annual Journal Metrics
39 days to first decision for reviewed manuscripts only
35 days to first decision for all manuscripts
91 days from submission to acceptance
11 days from acceptance to publication
291 Altmetric mentions